Rickettsial vaccines: The old and the new

Expert Review of Vaccines

Volumn 3, Issue 5, 2004, Pages 541-555

  Richards, Allen L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Epidemic typhus; Murine typhus; Orientia; Rickettsia; Rocky Mountain spotted fever; Scrub typhus

Indexed keywords

DNA VACCINE; LIVE VACCINE; MALTOSE BINDING PROTEIN BOR56; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN B; RECOMBINANT PROTEIN; RICKETTSIA VACCINE; TYPHUS VACCINE; UNCLASSIFIED DRUG;

BOUTONNEUSE FEVER; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MANUFACTURE; EGG YOLK; HAZARD; HISTORY OF MEDICINE; HUMAN; META ANALYSIS; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RICKETTSIA; RICKETTSIA PROWAZEKII; RICKETTSIOSIS; ROCKY MOUNTAIN SPOTTED FEVER; SCRUB TYPHUS; SIDE EFFECT; STANDARDIZATION; SYSTEMATIC REVIEW; TICK BORNE DISEASE; TYPHUS; VACCINE PRODUCTION;

ANIMALS; BOUTONNEUSE FEVER; CLINICAL TRIALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MODELS, ANIMAL; RICKETTSIA CONORII; RICKETTSIA INFECTIONS; RICKETTSIA RICKETTSII; RICKETTSIA TYPHI; RICKETTSIAL VACCINES; ROCKY MOUNTAIN SPOTTED FEVER; TYPHUS, ENDEMIC FLEA-BORNE; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VACCINES, SUBUNIT;

EID: 7444231630     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.3.5.541     Document Type: Review

References (137)

1. Moe JB, Pedersen CE Jr. The impact of rickettsial diseases on military operations. Milit. Med. 145, 780-785 (1980).
2. Woodward TE. The public's dept to military medicine. Milit. Med. 146, 168-173 (1981).
3. Walker DH. Biology of Rickettsial Diseases. CRC Press, Inc. Boca Raton, FL, USA (1988).
4. Kelly DJ, Richards AL, Temenak JJ, Strickman D, Dasch GA. The past and present threat of rickettsial diseases to military medicine and international public health. Clin. Infect. Dis. 34(Suppl. 4), 5145-5169 (2002).
5. Weiss E. The biology of rickettsiae. Ann. Rev. Microbiol. 36, 345-370 (1982).
6. Eremeeva ME, Dasch GA, Silverman DJ. Interaction of rickettsiae with eukaryotic cells. Adhesion, entry, intracellular growth, and host responses. In: Subcellular Biochemistry, Volume 33: Bacterial Invasion into Eukaryotic Cells. Oelschlaeger and Hacker (Eds). Kluwer Academic/Plenum Publishers, NY, USA, 479-516 (2000).
7. Heinzen RA, Hayes SF, Peacock MG, Hackstadt T. Directional actin polymerization associated with spotted fever group rickettsia infection of vero cells. Infect. Immun. 61, 1926-1935 (1993).
8. Gouin E, Egile C, Dehoux P et al. The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature 427, 457-461 (2004).
9. Jeng RL, Goley ED, D'Alessio JA et al. A rickettsia WASP-like protein activates the Arp2/3 complex and mediates actin-based motility. Cell Microbiol. 6, 761-769 (2004).
10. Anderson B, Friedman H, Bendinelli M. Rickettsial Infection and Immunity. Plenum Press, NY, USA (1997).
11. Murphy JR, Wisseman CL Jr, Fiset P. Mechanisms of immunity in typhus infection: some characteristics of Rickettsia mooseri infection in guinea-pigs. Infect. Immun. 21, 417-424 (1978).
12. Beaman L, Wisseman CL Jr. Mechanisms of immunity in typhus infections. VI. Differential opsonizing and neutralizing action of human typhus rickettsia-specific cyophilic antibodies in cultures of human macrophages. Infect. Immun. 14, 1071-1076 (1976).
13. Nacy CA, Osterman JV. Host defenses in experimental scrub typhus: role of normal and activated macrophages. Infect. Immun. 26, 744-750 (1979).
14. Valbuena G, Feng HM, Walker DH. Mechanisms of immunity against rickettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect. 4, 625-633 (2002).
15. Robinson DM, Huxsoll DL. Protection against scrub typhus infection engendered by the passive transfer of immune sera. Southeast Asian J. Trop. Med. Pub. Health 6, 477-482 (1975).
16. Murphy JR, Wisseman CL Jr, Fiset P. Mechanisms of immunity in typhus infection: analysis of immunity to Rickettsia mooseri infection of guinea-pigs. Infect. Immun. 27, 730-738 (1980).
17. Shirai A, Catanzaro PJ, Phillips SM, Osterman JV. Host defenses in experimental scrub typhus: role of cellular immunity in heterologous protection. Infect. Immun. 14, 39-46 (1976).
18. Nacy CA, Leonard EJ, Meltzer MS. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages. J. Immunol. 126, 204-207 (1981).
19. Jerrells TR, Turco J, Winkler HH, Spitalny GL. Neutralization of lymphokine-mediated antirickettsial activity of fibroblasts and macrophages with monoclonal antibody specific for murine interferon-γ. Infect. Immun. 51, 355-359 (1986).
20. A Carl M, Ching W-M, Dasch GA. Recognition of typhus group rickettsia-infected targets by human lymphokine-activated killer cells. Infect. Immun. 56, 2526-2529 (1988).
21. Hanson B. Susceptibility of Rickettsia tsutsugamushi Gilliam to interferon-γ in cultured mouse cells. Infect. Immun. 59, 4125-4133 (1991).
22. Seong S-Y, Huh M-S, Jang W-J et al. Induction of homologous immune response to Rickettsia tsutsugamushi Boryong with a partial 56-kilodalton recombinant antigen fused with the maltose-binding protein MBP-Bor56. Infect. Immun. 65, 1541-1545 (1997).
23. Walker DH, Popov VL, Feng HM. Establishment of a novel endothelial target mouse model of a typhus group rickettsiosis: evidence for critical roles for gamma Interferon and CD8 T-lymphocytes. Lab. Invest. 80, 1361-1372 (2000).
24. Billings AN, Feng HM, Olano JP, Walker DH. Rickettsial infection in murine models activates an early antirickettsial effect mediated by NK cells and associated with production of interferon-γ. Am. J. Trop. Med. Hyg. 65, 52-56 (2001).
25. Sekeyova Z, Roux V, Raoult D. Phylogeny of Rickettsia spp. inferred by comparing sequences of 'gene D', which encodes an intracytoplasmic protein. Int. J. Syst. Evol. Microbiol. 51, 1353-1360 (2001).
26. Tamura A, Ohasni N, Urakami H, Miyamura S. Classification of Rickettsia tsutsugamushi in a new genus, Orientia gen. nov., as Orientia tsutsugamushi comb. nov. Intern. J. Syst. Bacteriol. 45, 589-591 (1995).
27. Burnett JW. Rickettsioses: a review for the dermatologist. J. Am. Acad. Dermatol. 2, 359-373 (1980).
28. Gross L. How Charles Nicolle of the Pasteur Institute discovered that epidemic typhus is transmitted by lice reminiscences from my years at the Pasteur Institute in Paris. Proc. Natl Acad. Sci. USA 93, 10539-10540 (1966).
29. Biraud Y. The present menance of typhus fever in Europe and the means of combating it. Bull. Health Org. League of Nations 10, 1-64 (1943). Very good review written at the time of the development of living vaccines for typhus.
30. Wisseman CL Jr. Concepts of louse-borne typhus control in developing countries: the use of the living attenuated E strain typhus vaccine in epidemic and endemic situations. Adv. Exp. Med. Biol. 31, 97-130 (1972).
31. Spencer RR, Parker RR. Rocky Mountain spotted fever vaccination of monkeys and man. Public Health Rep. 40, 2159-2167 (1925).
32. Castaneda MR. Experimental pneumonia produced by typhus rickettsiae. Am. J. Pathol. 15, 467-475 (1939).
33. Woodward TE. Rickettsial vaccines with emphasis on epidemic typhus. Initial report of an old vaccine trial. S. Afr. Med. J. 11(Suppl.), 73-76 (1986).
34. Weiss K, Walker DH. New and improved vaccines against rickettsial infections. Rocky Mountain spotted fever, epidemic typhus, and scrub typhus. In: New Generation Vaccines. Woodrow GE, Levine MM (Eds). Marcel Dekker Inc., NY, USA, 357-374 (1990). Very good review of rickettsial vaccines.
35. Long AP. The Army Immunization Program. In: Preventive Medicine in World War II. Volume III. Personal Health Measures and Immunization, Office of the Surgeon General, Department of the Army, Washington, DC, USA, Chapter VIII, 319-323 (1955).
36. Gear JH. Rickettsial vaccines. Br. Med. Bull. 25, 171-176 (1969).
37. Cox HR. Cultivation of rickettsiae of the Rocky Mountain spotted fever, typhus, and Q fever groups in the embryonic tissues of developing chicks. Science 94, 399-403 (1941).
38. Smadel JE, Jackson EB, Campbell JM. Studies on epidemic typhus vaccine. Arch. Inst. Pasteur Tunis 36, 481-499 (1959).
39. Murray ES, Kmet J, Jung M, O'Connor JM, Gaon JA. Antibody response to a typhus vaccine booster in individuals previously sensitized by either a typhus infection or a single injection of typhus vaccine. J. Hyg. Epidemiol. Microbiol. Immun. 12, 7-13 (1968).
40. Dasch GA, Burans JP, Dobson ME, Rollwagen FM, Misiti J. Approaches to subunit vaccines against the typhus rickettsiae, Rickettsia typhi and Rickettsia prowazekii. In: Microbiology. Schlessinger (Ed.). American Society for Microbiology, Washington DC, USA, 251-256 (1984).
41. Advisory Committee on Immunization Practices, US Public Health Service. Typhus vaccine. Recommendation on immunization practices. Ann. Internatl Med. 69, 785-786 (1968).
42. Fox JP. Immunization against epidemic typhus. A brief general review and a description of the status of living, avirulent R. prowazeki (strain E) as an immunizing agent. Am. J. Trop. Med. Hyg. 5, 464-479 (1956). Describes the Madrid E attenuated vaccine for epidemic typhus.
43. Perez Gallardo F, Fox JP. Infection and immunization of laboratory animals with Rickettsia prowazekii of reduced pathogenicity, strain E. Am. J. Hyg. 48, 6-21 (1948).
44. Fox JP. A review of experience with an avirulent strain of R. prowazeki (strain E) as a living agent for immunizing man against epidemic typhus. Am. J. Pub. Health 45, 1036-1048 (1955).
45. Fox JP, Montoya JA, Jordan ME et al. Immunization of man against epidemia typhus by infection with avirulent Rickettsia prowazeki (Strain E). V. A brief review and observations during a 31/2 year period as to the occurrence of typhus among vaccinated and control populations in the Peruvian Andes. Arch. Inst. Pasteur Tunis 36, 449-479 (1959).
46. Golinevich EM, Yablonskaya VA. Live typhus vaccine prepared from strain 'E' of Rickettsia prowazeki. J. Hyg. Epi. Microbiol. Immunol. 7, 290-300 (1963).
47. Wisseman CL Jr, el Batawi Y, Wood WH Jr, Noriega AR. Gross and microscopic skin reactions to killed typhus rickettsiae in human beings. J. Immunol. 98, 194-209 (1967).
48. Cohen SS, Chambers LA, Clawson JR. Studies on commercial typhus vaccines III. The concentration and isolation of the rickettsia-specific soluble antigen of commercial typhus vaccine. J. Immunol. 65, 465-473 (1950).
49. Golinevitch HM, Vovonova ZA. The superficial protective antigen of R prowazekii. J. Hyg. Epidemiol. Microbiol. Immunol. 12, 413-419 (1968).
50. Kokorin IN, Pushkareva VI, Miskarova ED. Immunogenicity of Rickettsia prowazekii antigens. In: Rickettsia and Rickettsial Diseases. Kazar J (Ed.). Publishing House of the Slovak Academy of Sciences, Bratislava, Czechoslovakia, 254 (1985).
51. Dasch GA, Bourgeois AL. Antigens of the typhus group of rickettsiae: importance of the species-specific surface protein antigens in eliciting immunity. In: Rickettsiae and Rickettsial Diseases. Burgdorfer W, Anacker RL (Eds). Academic Press, NY, USA, 61-70 (1981).
52. Bourgeois AL, Dasch GA. The species-specific surface protein antigen of Rickettsia typhi: immunogenicity and protective efficacy in guinea-pigs. In: Rickettsiae and Rickettsial Diseases. Burgdorfer W, Anacker RL (Eds). Academic Press, NY, USA, 71-80 (1981).
53. Dasch GA, Bourgeois AL, Rollwagen FM. The surface protein antigen of Rickettsia typhi: in vitro and in vivo immunogenicity and protective efficacy in mice. In: Rickettsiae and Rickettsial Diseases at the Turn of the Third Millenium. Raoult D, Brouqui P (Eds). Elsevier, Paris, France, 116-122 (1999).
54. Carl M, Dobson ME, Ching W-M, Dasch GA. Characterization of the gene encoding the protective paracrystalline-surface-layer protein of Rickettsia prowazekii: Presence of a truncated identical homolog in Rickettsia typhi. Proc. Natl Acad. Sci. USA 87, 8237-8241 (1990).
55. Carl M, Dasch GA. The importance of the crystalline surface layer protein antigens of rickettsiae in T-cell immunity. J. Autoimmun. 2(SuppL), 81-91 (1989).
56. Churilla A, Ching W-M, Dasch GA, Carl M. Recognition of synthetic peptides by rickettsia specific human T-lymphocytes. In: Rickettsiae and Rickettsial Diseases. Kazar J, Raoult D (Eds). VEDA, Bratislava, Czechoslovakia, 296-305 (1990).
57. Ching W-M, Carl M, Dasch GA. Mapping of monoclonal antibody binding sites on CNBr fragments of the S-layer protein antigens of Rickettsia typhi and Rickettsia prowazekii. Mol. Immunol. 29, 95-105 (1992).
58. Ching W-M, Wang H, Jan B, Dasch GA. Identification and characterization of epitopes on the 120-kilodalton surface protein antigen of Rickettsia prowazekii with synthetic peptides. Infect. Immun. 64, 1413-1419 (1996).
59. Winkler HH, Daugherty RM. Phospholipase A activity associated with the growth of Rickettsia prowazekii in L929 cells. Infect. Immun. 57, 36-40 (1989).
60. Silverman DJ, Santucci LA, Meyers N, Sekeyova Z. Penetration of host cells by Rickettsia rickettsii appears to be medicated by a phospholipase of rickettsial origin. Infect. Immun. 60, 2733-2740 (1992).
61. Walker DH, Feng HM, Popov VL. Rickettsial phospholipase A2 as a pathogenic mechanism in a model of cell injury by typhus and spotted fever group rickettsiae. Am. J. Trop. Med. Hyg. 65, 936-942 (2001).
62. Renesto P, Dehoux P, Gouin E et al. Identification and characterization of a phospholipase D-superfamily gene in rickettsiae. J. Infect. Dis. 188, 1276-1283 (2003).
63. Radulovic S, Troyer JM, Beier MS, Lau AO, Azad AF. Identification and molecular analysis of the gene encoding Rickettsia typhi hemolysin. Infect. Immun. 67, 6104-6108 (1999).
64. Andersson SG, Zomorodipour A, Andersson JO et al. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396, 130-140 (1998).
65. Ogata H, Audic S, Renesto-Audiffren P et al. Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 293, 2093-2098 (2001).
66. Ohashi N, Zhi N, Lin Q, Rikihisa Y. Characterization and transcriptional analysis of gene clusters for a Type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents. Infect. Immun. 70, 2128-2138 (2002).
67. Gaywee J, Sacci JB Jr, Radulovic S, Beier M, Azad AF. Subcellular localization of rickettsial invasion protein INVA. Am. J. Trop. Med. Hyg. 68, 92-96 (2003).
68. Ge H, Chuang Y-Y, Zhao S et al. Comparative genomics of Rickettsial prowazekii Madrid E and Breinl strains. J. Bacteriol. 186, 556-565 (2004). Demonstrates for the first time the use of microarray technology for the study of rickettsia.
69. Coker C, Majid M, Radulovic S. Development of Rickettsia prowazekii DNA vaccine. Cloning strategies. Ann. NY Acad. Sci. 990, 757-764 (2003). Discusses the use of the genomic sequence of Rickettsia prowazekii in selecting potential vaccine candidates.
70. Houhamdi L, Fournier PE, Fang R, Lepidi H, Raoult D. An experimental model of human body louse infection with Rickettsia prowazekii. J. Infect. Dis. 186, 1639-1646 (2002).
71. Reynolds MG, Krebs JW, Comer JA et al. Flying squirrel-associated typhus, United States. Emerg. Infect. Dis. 9, 1341-1343 (2003).
72. Barker LF, Palmer AE, Kirschstein RL, Hopps HE, Patt JK. Experimental infection with Rickettsia prowazekii in rhesus and vervet monkeys. J. Infect. Dis. 117, 285-291 (1967).
73. Gonder JC, Kenyon RH, Pedersen CE Jr. Epidemic typhus infection in cynomolgus monkeys (Macaca fascicularis). Infect. Immun. 30, 219-223 (1980).
74. Azad AF. Epidemiology of murine typhus. Ann. Rev. Entomol. 35, 553-569 (1990). Excellent review of murine typhus.
75. Zdrodovsky PF, Golinevich HM. The Rickettsial Diseases. Pergamon Press, NY, USA (1960).
76. Traub R, Wisseman CL Jr, Farhang-Azad A. The ecology of murine typhus - a critical review. Trop. Dis. Bull. 75, 237-317 (1978).
77. Azad AF, Traub R. Experimental transmission of murine typhus by Xenopsylla cheopis flea bites. Med. Vet. Entomol. 3, 429-433 (1989).
78. Houhamdi L, Fournier PE, Fang R, Raoult D. An experimental model of human body louse infection with Rickettsia typhi. Ann. NY Acad. Sci. 990, 617-627 (2003).
79. Arango-Jaramillo S, Farhang-Azad A, Wisseman CL Jr. Experimental infection with Rickettsia mooseri and antibody response of adult and newborn laboratory rats. Am. J. Trop. Med. Hyg. 33, 1017-1025 (1984).
80. Parker RR. Rocky Mountain spotted fever: results of fifteen years' prophylactic vaccination. Am. J. Trop. Med. 21, 369-383 (1941).
81. Cox HR. Rocky Mountain spotted fever: protective value for guinea-pigs of vaccine prepared from rickettsiae cultivated in embryonic chick tissues. Public Health Rep. 54, 1070-1077 (1939).
82. Lackman D, Parker RR. Comparison of the immunogenic and anaphylactogenic properties of Rocky Mountain spotted fever vaccines prepared from infected yolk sacs and from infected tick tissue. Am. J. Public Health 38, 1402-1404 (1948).
83. DuPont HL, Hornick RB, Dawkins AT et al. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J. Infect. Dis. 128, 340-344 (1973).
84. Kenyon RH, Pedersen CE Jr. Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization. J. Clin. Microbiol. 1, 500-503 (1975).
85. Kenyon RH, Sammons LSC, Pedersen CE Jr. Comparison of three Rocky Mountain spotted fever vaccines. J. Clin. Microbiol. 2, 300-304 (1975).
86. Ascher MS, Oster CN, Harber PI, Kenyon RH, Pedersen CE Jr. Initial clinical evaluation of a new Rocky Mountain spotted fever vaccine of tissue culture origin. J. Infect. Dis. 138, 217-221 (1978).
87. Clements ML, Wisseman CL Jr, Woodward et al. Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever. J. Infect. Dis. 148, 922-930 (1983).
88. Anacker RL, List RH, Mann RE, Hayes SF, Thomas LA. Characterization of monoclonal antibodies protecting mice against Rickettsia rickettsii. J. Infect. Dis. 151, 1052-1060 (1985).
89. McDonald GA, Anacker RL, Mann RE, Milch LJ. Protection of guinea-pigs from experimental Rocky Mountain spotted fever with cloned antigen of Rickettsia rickettsii. J. Infect. Dis. 158, 228-231 (1988).
90. Vishwanath S, McDonald GA, Watkins NG. A recombinant Rickettsia conorii vaccine protects guinea-pigs from experimental boutonneuse fever and Rocky Mountain spotted fever. Infect. Immun. 58, 646-653 (1990).
91. Diaz-Montero CM, Feng H-M, Crocquiet-Valdes PA, Walter DH. Identification of protective components of two major outer membrane proteins of spotted fever group rickettsiae. Am. J. Trop. Med. Hyg. 65, 371-378 (2001).
92. Crocquet-Valdes PA, Díaz-Montero CM, Feng HM et al. Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. Vaccine 20, 979-988 (2002).
93. Renesto P, Raoult D. From genes to proteins. In vitro expression of rickettsial proteins. Ann. NY Acad. Sci. 990, 642-652 (2003).
94. Sammons LS, Kenyon RH, Hickman RL, Pedersen CE Jr. Susceptibility of laboratory animals to infection by spotted fever rickettsiae. Lab. Animal Sci. 27, 229-234 (1977).
95. Ormsbee R, Peacock M, Gerloff R, Tallent G, Wike D. Limits of rickettsial infectivity. Infect. Immun. 19, 239-245 (1978).
96. Fan M-Y, Wang J-G, Jiang Y-X et al. Isolation of a spotted fever group rickettsia from a patient and related ecologic investigations in Xinjiang Uygur autonomous region of China. J. Clin. Microbiol. 25, 628-632 (1987).
97. Eisemann CS, Nypaver MJ, Osterman JV. Susceptibility of inbred mice to rickettsiae of the spotted fever group. Infect. Immun. 43, 143-148 (1984).
98. Dasch GA, Weiss E. The Genera Rickettsia, Rochalimaea, Ehrlichia, Cowdria, and Neorickettsia. In: The Prokaryotes: A Handbook on the Biology of Bacteria, Volume 3. Balows A (Ed.). Springer-Verlag, NY, USA, 2407-2470 (1992).
99. Blake FG, Maxcy KF, Sadusk JF Jr, Kohls GM, Bell EJ. Studies on tsutsugamushi disease (scrub typhus, mite-borne typhus) in New Guinea and adjacent islands: epidemiology, clinical observations, and etiology in the Dobadura area. Am. J. Hygiene 41, 243-373 (1945).
100. Deller JJ Jr, Russell PK. An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann. Intern. Med. 66, 1129-1143 (1967).
101. Cross JH, Basaca-Sevilla V. Seroepidemiology of scrub typhus and murine typhus in the Philippines. Philippine J. Microbiol. Infect. Dis. 10, 25-34 (1981).
102. Watt G, Strickman D. Life-threatening scrub typhus in a traveler returning from Thailand. Clin. Infect. Dis. 18, 624-626 (1994).
103. Gormley TS. A diagnosis of scrub typhus. Navy Med. 87, 20-22 (1996).
104. Eamsila C, Singsawat P, Duangvaraporn A, Strickman D. Antibodies to Orientia tsutsugamushi in Thai soldiers. Am. J. Trop. Med. Hyg. 55, 556-559 (1996).
105. Richards AL, Teik OC, Lockman JL, Rahardjo E, Wignall FS. Scrub typhus in an American living in Jakarta, Indonesia: a case report. Infect. Dis. Clin. Practice 6, 268-273 (1997).
106. Watt G, Chouriyagune C, Ruangweerayud R et al. Scrub typhus infections poorly responsive to antibiotics in northern Thailand. Lancet 348, 86-89 (1996). Reports the first description of scrub typhus unresponsive to standard antibiotic treatment.
107. Mathai E, Rolain JM, Verghese GM et al. Outbreak of scrub typhus in southern India during the cooler months. Ann. NY Acad. Sci. 990, 359-364 (2003).
108. Fulton F, Joyner L. Cultivation of Rickettsia tsutsugamushi in lungs of rodents. Preparation of a scrub typhus vaccine. Lancet 2, 729-733 (1945).
109. Buckland FE, MacCallum FO, Dudgeon A et al. Scrub typhus vaccine. Large-scale production. Lancet 2, 734-737 (1945).
110. Smadel JE, Rights FL, Jackson EB. Studies on scrub typhus. II. Preparation of formalinized vaccines from tissues of infected mice and rats. Proc. Soc. Exp. Biol. 61, 308-313 (1946).
111. Plotz H, Bennett BL, Reagan RL. Preparation of an inactivated tissue culture scrub typhus vaccine. Proc. Soc. Exp. Biol. 61, 313-317 (1946).
112. Bailey CA, Diercks FH, Proffitt JE. Preparation of a serological antigen and a vaccine for experimental tsutsugamushi disease (scrub typhus). J. Immunol. 50, 431-441 (1948).
113. Card WI, Walker JM. Scrub typhus vaccine: field trial in South-east Asia. Lancet 252, 481-483(1947).
114. Derrick EH, Brown HE. Isolation of the Karp strain of Rickettsia tsutsugamushi. Lancet 2, 150-151 (1949).
115. Berge TO, Gauld RL, Kitaoka M. A field trial of a vaccine prepared from the Volner strain of Rickettsia tsutsugamushi. Am. J. Hyg. 50, 337-342 (1949).
116. Kawamura R, Kasahara S, Toyama T, Nishinarita F, Tsubaki S. On the prevention of tsutsugamushi. Results of preventive inoculations for people in the endemic region, and laboratory tests with the Pescadore strain. Kitasato Arch. Exp. Med. 16, 93-109 (1939).
117. Rights FL, Smadel JE. Studies on scrub typhus (tsutsugamushi disease). III. Heterogenicity of strains of R. tsutsugamushi as demonstrated by cross-vaccination studies. J. Exp. Med. 87, 339-351 (1948).
118. Smadel JE, Ley HL Jr, Diercks FH, Traub R. Immunity in scrub typhus: resistance to induced reinfection. Arch. Path. 50, 847-861 (1950).
119. Smadel JE, Ley HL Jr, Diercks FH et al. Immunization against scrub typhus: duration of immunity in volunteers following combined living vaccine and chemoprophylaxis. Am. J. Trop. Med. Hyg. 1, 87-97 (1952).
120. Jackson EB, Smadel JE. Immunization against scrub typhus. II. Preparation of lyophilized living vaccine. Am. J. Hyg. 53, 326-331 (1951).
121. Shirai A, Catanzaro PJ, Eisenberg GHG Jr, Osterman JV. Host defenses in experimental scrub typhus: effect of chloramphenicol. Infect. Immun. 18, 324-329 (1977).
122. Eisenberg GHG Jr, Osterman JV. Experimental scrub typhus immunogens: γ-irradiated and formalinized rickettisae. Infect. Immun. 15, 124-131 (1977).
123. Eisenberg GHG Jr, Osterman JV. γ-irradiated scrub typhus immunogens: development and duration of immunity. Infect. Immun. 22, 80-86 (1978).
124. Eisenberg GHG Jr, Osterman JV. γ-irradiated scrub typhus immunogens: broad spectrum immunity with combinations of rickettsial strains. Infect. Immun. 26, 131-136 (1979).
125. Oaks EV, Stover CK, Rice RM. Molecular cloning and expression of Rickettsia tsutsugamushi genes for two major protein antigens in Escherichia coli. Infect. Immun. 55, 1156-1162 (1987).
126. Oaks EV, Rice RM, Kelly DJ, Stover CK. Antigenic and genetic relatedness of eight Rickettsia tsutsugamushi antigens. Infect. Immun. 57, 3116-3122 (1989).
127. Stover CK, Marana DP, Dasch GA, Oaks EV. Molecular cloning and sequence analysis of the sta58 major antigen gene of Rickettsia tsutsugamushi: sequence homology and antigenic comparison of sta58 to the 60-kilodalton family of stress proteins. Infect. Immun. 58, 1360-1368 (1990).
128. Stover CK, Marana DP, Carter JM et al. The 56-kilodalton major protein antigen of Rickettsia tsutsugamushi: molecular cloning and sequence analysis of the sta56 gene and precise identification of a strain-specific epitope. Infect. Immun. 58, 2076-2084 (1990).
129. Hickman CJ, Stover Ck, Joseph SW, Oaks EV. Molecular cloning and sequence analysis of a Rickettsia tsutsugamushi 22 kDa antigen containing B- and T-cell epitopes. Microb. Pathog. 11, 19-31 (1991).
130. Hickman CJ, Stover CK, Joseph SW, Oaks EV. Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi. Infect. Immun. 61, 1674-1681 (1993).
131. Niu D, Chen W, Zhang X et al. Immunogenicity of a 40 kDa fragment of the 47 kDa recombinant protein and DNA vaccine from Karp strain of Orientia tsutsugamushi. Ann. NY Acad. Sci. 990, 527-534 (2003).
132. Kim IS, Seong SY, Woo SG, Choi MS, Chang WH. High-level expression of a 56-kilodalton protein gene (bor56) of Rickettsia tsutsugamushi Boryong and its application to enzyme-linked immunosorbent assays. J. Clin. Microbiol. 31, 598-605 (1993).
133. Ching W-M, Wang H, Eamsila, Kelly DJ, Dasch GA. Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in enzyme-linked immunosorbent assays. Clin. Diagn. Lab. Immunol. 5, 519-526 (1998).
134. Jiang J, Marienau KJ, May LA et al. Laboratory diagnosis of two scrub typhus outbreaks at Camp Fuji, Japan (2000, 2001) by ELISA, RFA and WB using outer membrane 56 kDa recombinant proteins. Am. J. Trop. Med. Hyg. 69, 60-66 (2003).
135. Chen WJ, Niu DS, Zhang XY et al. Recombinant 56-kilodalton major outer membrane protein antigen of Orientia tsutsugamushi Shanxi and its antigenicity. Infect. Immun. 71, 4772-4779 (2003).
136. Chattopadhyay S, Jiang J, Chan T-C et al. Successful induction of humoral and cellular immune responses in cynomolgus monkeys to the scrub typhus vaccine candidate, Kpr56. J. Immunol. Submitted (2004).
137. Ni YS, Chan TC, Chao CC et al. Protection against scrub typhus by a plasmid vaccine encoding the 56 kDa outer membrane protein antigen gene. Vaccine. Submitted (2004).